4//SEC Filing
Gladstone Michael 4
Accession 0001209191-22-039064
CIK 0001845337other
Filed
Jun 22, 8:00 PM ET
Accepted
Jun 23, 8:27 PM ET
Size
6.1 KB
Accession
0001209191-22-039064
Insider Transaction Report
Form 4
Gladstone Michael
Director
Transactions
- Award
Director Stock Option (Right to buy Common Stock)
2022-06-21+28,700→ 28,700 totalExercise: $16.29Exp: 2032-06-20→ Common Stock (28,700 underlying)
Footnotes (2)
- [F1]The option vests as to 1/12th of the total shares on each monthly anniversary, beginning on July 21, 2022, subject to the Reporting Person's provision of service to the Issuer on each vesting date.
- [F2]The Reporting Person is a member of Atlas Venture Associates XI, LLC and is obligated to transfer the economic benefit, if any, received upon the sale of the shares issuable upon exercise of the equity grants to Atlas Venture Life Science Advisors, LLC. As such, the Reporting Person disclaims beneficial ownership of the securities reported herein for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, except to the extent of his pecuniary interest therein, if any.
Documents
Issuer
Day One Biopharmaceuticals, Inc.
CIK 0001845337
Entity typeother
Related Parties
1- filerCIK 0001864256
Filing Metadata
- Form type
- 4
- Filed
- Jun 22, 8:00 PM ET
- Accepted
- Jun 23, 8:27 PM ET
- Size
- 6.1 KB